Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease

Sponsor
Minneapolis Heart Institute Foundation (Other)
Overall Status
Recruiting
CT.gov ID
NCT04525937
Collaborator
(none)
200
1
49.9
4

Study Details

Study Description

Brief Summary

Common barriers to receiving appropriate guideline-driven care for patients with severe aortic stenosis include referral biases by primary care providers (lack of provider education), patient comorbidities (degree of fragility), as well as psychosocial issues and cultural barriers. Additionally, race, ethnicity, socioeconomic status (SES) and education level are shown to be persistent barriers to accessing healthcare services and healthcare systems, creating a significant practice gap between various patient populations. The most recent transcatheter valve therapies (TVT) registry data show that >94% of TAVR recipients are Caucasian, followed by less than 4% of African-Americans and Hispanics, respectively. There is a critical need to understand the barriers to treatment and care among severe aortic valve disease patients of disparate groups. This study is a multi-center, retrospective and prospective cohort study of patients diagnosed with severe aortic stenosis. Additionally, we will be surveying referring primary care providers, cardiologists and cardiovascular surgeons to assess their current referral practices for patients with severe aortic stenosis.

Condition or Disease Intervention/Treatment Phase
  • Other: Patient Questionnaire
  • Other: Provider Questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Racial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease
Actual Study Start Date :
Jun 4, 2018
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients with Severe Aortic Stenosis with Disparities

Patients will complete a survey and their aortic stenosis will be clinically followed at 30 days and one year

Other: Patient Questionnaire
Patient Questionnaire

Medical Providers with Disparities

Referring primary care providers complete a questionnaire on their referral practices for patients with severe aortic stenosis

Other: Provider Questionnaire
Provider Questionnaire

Outcome Measures

Primary Outcome Measures

  1. Patient Mortality [30 days and 1 year]

  2. MACE (Major Adverse Cardiac Event) [30 days and 1 year]

Secondary Outcome Measures

  1. Referring physician- related barriers/biases. [through study completion, an average of 1 year]

    Secondary outcomes (Providers): referring physician-related barriers/biases against routine guideline-driven care for members of disparate groups with severe aortic stenosis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Disparity/Diversity background (either race/ethnicity, low SES (adults with incomes at or below the federal poverty level (family income to poverty ratio, ≤1), language (non-English speaker) or education (≤9 years of education))

  • Patient scheduled for transcatheter aortic valve replacement using the Edwards Sapien valve, OR recently implanted with Edwards Sapien valve (up to 1 year post-TAVR)

  • Echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score

Exclusion Criteria:
  • Age < 18

  • Patients who do not allow their records to be used for research

Contacts and Locations

Locations

Site City State Country Postal Code
1 Minneapolis Heart Institute Foundation Minneapolis Minnesota United States 55407

Sponsors and Collaborators

  • Minneapolis Heart Institute Foundation

Investigators

  • Principal Investigator: Mario Goessl, MD, PhD, Minneapolis Heart Institute Foundation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Minneapolis Heart Institute Foundation
ClinicalTrials.gov Identifier:
NCT04525937
Other Study ID Numbers:
  • Racial Disparities
First Posted:
Aug 25, 2020
Last Update Posted:
Apr 8, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Minneapolis Heart Institute Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2022